Investment
Features
FeesSafety
Academy
More
Pluang+

Compare IDEXX Laboratories, Inc. (IDXX) vs Invesco Ltd. (IVZ) Price & Performance

IDEXX Laboratories, Inc.Trade
Invesco Ltd.Trade

Price performance (Past 24H)

Key statistics

IDEXX Laboratories, Inc. vs Invesco Ltd. — how do they compare? IDEXX Laboratories, Inc. trades at $546.1 (market cap $43.58B), while Invesco Ltd. trades at $30.5 (market cap $13.34B). The key difference: IDEXX Laboratories, Inc. is far larger — about 3.3× Invesco Ltd.'s market cap, and Invesco Ltd. pays a 2.86% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.

IDXXIVZ
Market Cap
$43.58B$13.34B
Sector
HealthFinancials
52-Week High
$766.68$30.30
52-Week Low
$526.44$20.45
Enterprise Value
$44.48B$23.59B
Dividend Yield
2.86%

Returns comparison

Trailing returns across standard periods

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX

About Invesco Ltd.

Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).

Read more on IVZ